APOA1 and Cognitive impairment: The serum concentration of cognitive impairment-linked biomarkers revealed an increase in apolipoprotein A1 (ApoA1) and Transthyretin (TTR) levels in the experimental group at 16 weeks (Watanabe et al., 2006).